Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jul 7;157(4):e202513778.
doi: 10.1085/jgp.202513778. Epub 2025 Apr 28.

Sensory neuron sodium channels as pain targets; from cocaine to Journavx (VX-548, suzetrigine)

John N Wood  1 , Nieng Yan  2   3 , Jian Huang  3 , Jing Zhao  1 , Armen Akopian  4 , James J Cox  1 , C Geoffrey Woods  5 , Mohammed A Nassar  6
Affiliations
Review

Sensory neuron sodium channels as pain targets; from cocaine to Journavx (VX-548, suzetrigine)

John N Wood et al. J Gen Physiol. .

Abstract

Voltage-gated sodium channels underpin electrical signaling in sensory neurons. Their activity is an essential element in the vast majority of pain conditions, making them significant drug targets. Sensory neuron sodium channels play roles not only in afferent signaling but also in a range of efferent regulatory mechanisms. Side effects through actions on other cell types and efferent signaling are thus important issues to address during analgesic drug development. As an example, the human genetic evidence for NaV1.7 as an ideal pain target contrasts with the side effects of NaV1.7 antagonists. In this review, we describe the history and progress toward the development of useful analgesic drugs and the renewed focus on NaV1.8 as a key target in pain treatment. NaV1.8 antagonists alone or in combination with other analgesics are likely to provide new opportunities for pain relief for the vast number of people (about 33% of the population) impacted by chronic pain, particularly present in aging populations.

PubMed Disclaimer

Conflict of interest statement

Disclosures: The authors declare no competing interests exist.

References

    1. Akopian, A.N., Sivilotti L., and Wood J.N.. 1996. A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons. Nature. 379:257–262. 10.1038/379257a0 - DOI - PubMed
    1. Akopian, A.N., Souslova V., England S., Okuse K., Ogata N., Ure J., Smith A., Kerr B.J., McMahon S.B., Boyce S., et al. 1999. The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways. Nat. Neurosci. 2:541–548. 10.1038/9195 - DOI - PubMed
    1. Alexandrou, A.J., Brown A.R., Chapman M.L., Estacion M., Turner J., Mis M.A., Wilbrey A., Payne E.C., Gutteridge A., Cox P.J., et al. 2016. Subtype-selective small molecule inhibitors reveal a fundamental role for Nav1.7 in nociceptor electrogenesis, axonal conduction and presynaptic release. PLoS One. 11:e0152405. 10.1371/journal.pone.0152405 - DOI - PMC - PubMed
    1. Bagal, S.K., Chapman M.L., Marron B.E., Prime R., Storer R.I., and Swain N.A.. 2014. Recent progress in sodium channel modulators for pain. Bioorg. Med. Chem. Lett. 24:3690–3699. 10.1016/j.bmcl.2014.06.038 - DOI - PubMed
    1. Bangash, M.A., Alles S.R.A., Santana-Varela S., Millet Q., Sikandar S., de Clauser L., Ter Heegde F., Habib A.M., Pereira V., Sexton J.E., et al. 2018. Distinct transcriptional responses of mouse sensory neurons in models of human chronic pain conditions. Wellcome Open Res. 3:78. 10.12688/wellcomeopenres.14641.1 - DOI - PMC - PubMed